Portola Pharmaceuticals Highlights Presentation Of New In Vitro Data Demonstrating That Four-Factor Prothrombin Complex Concentrates (4F-PCCs) Had No Direct Effect On Inhibition Of Thrombin Generation By Factor Xa Inhibitors